“
“Objective: This study included 1226 pregnant women who gave birth in our hospital’s Department of Obstetrics and their newborns to evaluate the effects of maternal smoking on neonatal anthropometric measurements.\n\nMaterial Volasertib supplier and Method: Information about daily cigarette smoking patterns were collected by a questionnaire and the neonatal anthropometric measurements were recorded. The mothers with high risk pregnancies, multiple births and chronic diseases and the preterms, neonates with congenital

anomalies and hospitalized neonates were excluded.\n\nResults: Of the 1226 women 940 (76.6%) never smoked; while 286 (23.4%) were smoker. Two hundred and five mothers smoking 1-5 cigarettes daily were classified as mild smokers, whereas 81 women smoking more than 5 cigarettes daily as heavy smoker. Eighty one heavy smokers constituted 28.3% of the 286 mothers who smoked and the 6.7% of the whole study population. There as no statistical difference between smokers and non-smokers Captisol regarding to socio-cultural and economic status. The average weight, height, chest and head circumference of children born from heavy smoker mother group was 160 gr, 0.65 cm, 0.38 cm and 0.28 cm smaller than the non-smoker group respectively. A statistically significant difference was found regarding height and weight, but not for head and chest

circumference.\n\nConclusion: It was found that as the number of Saracatinib datasheet cigarettes smoked increased by mother, especially the weight of the newborn decreased and the height also is adversely affected.”
“Background Genetic analysis of choroidal melanoma is frequently used to estimate the risk of metastatic spread of the tumor. Obtaining a biopsy for genetic analysis, however, can be

difficult and sometimes unsuccessful. We evaluated the feasibility and accuracy of genetic testing using array comparative genomic hybridization (CGH) after radiotherapy, from tumor samples obtained by endoresection or after secondary enucleation. Material and methods Fifteen choroidal melanoma samples obtained after radiotherapy (Ruthenium-106 plaque brachytherapy or Gamma-Knife radiosurgery) were analyzed by array CGH to detect chromosomal aberrations (monosomy 3 and trisomy 8q), and the results were compared with pre-irradiation findings in five cases. Results Array CGH was successfully performed in all 15 cases. Time from radiotherapy to obtaining the sample for cytogenetic testing was between 14 and 879 days. Results of post-radiotherapy genetic analysis did not differ from pre-radiotherapy findings. Conclusion Post-radiation CGH appears to be a promising option for prognostic testing if a first biopsy before radiotherapy failed or was not performed. It could be useful to avoid an additional surgical procedure before radiotherapy if vitrectomy or endoresection is planned after radiotherapy.